Maze Therapeutics, Inc. Common Stock (MAZE) — Cash Flow Reinvestment Rate
Maze Therapeutics, Inc. Common Stock (MAZE) has a Cash Flow Reinvestment Rate of 0.00x as of June 2024, reinvesting $320.00K (capex $160.00K plus investments $-160.00K) from operating cash flow of $145.05 Million. See free cash flow generation of Maze Therapeutics, Inc. Common Stock to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Maze Therapeutics, Inc. Common Stock Cash Flow Reinvestment Rate (2024–2024)
Historical reinvestment intensity for Maze Therapeutics, Inc. Common Stock across 1 annual periods. For the full cash flow conversion analysis, see MAZE cash generation efficiency.
Annual Cash Flow Reinvestment Rate for Maze Therapeutics, Inc. Common Stock (2024–2024)
Year-by-year capital reinvestment analysis for Maze Therapeutics, Inc. Common Stock. See MAZE financial flexibility score to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.03x | $2.29 Million | $75.95 Million | $1.15 Million | — |